Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gennarelli, G.
Right arrow Articles by Lithell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gennarelli, G.
Right arrow Articles by Lithell, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 535-541, Copyright © 1998 by Oxford University Press


ARTICLES

Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?

G Gennarelli, J Holte, L Wide, C Berne and H Lithell
Department of Obstetrics and Gynecology, Uppsala University, Sweden.

Immunoreactive serum leptin was analysed in 49 women with polycystic ovary syndrome (PCOS) distributed on a wide range of body mass index (BMI; kg/m2) and in 32 normally menstruating women with comparable age, BMI, physical activity and dietary habits. All women with PCOS had increased androgen concentrations and obese women with PCOS (BMI > or = 25, n=24) also showed decreased insulin sensitivity and a preferential accumulation of truncal-abdominal body fat. Anthropometric and hormonal variables, insulin sensitivity, and pancreatic beta-cell activity were investigated in all women. Percentage body fat was calculated using gender-specific regression equations based on skinfold measurements. Serum leptin concentrations were higher in obese than in non-obese women (P < 0.001), but did not differ between the women with PCOS and controls, nor did they differ between glucose intolerant and glucose tolerant, or hirsute and non-hirsute women with PCOS. Both groups showed strong correlations between serum leptin concentrations and percentage body fat, BMI, body fat distribution, fasting plasma insulin and C-peptide, early insulin secretion, the free androgen index (FAI), and the degree of insulin resistance. After correcting for percentage body fat, only the FAI in the women with PCOS remained significant (P < 0.05). However, in a multiple regression analysis with both percentage body fat and the FAI as independent variables, the FAI increased only minimally (2%) the explained variation in leptin concentrations. Thus, serum leptin concentrations are almost exclusively determined by the total amount of body fat, independent of its location, and do not confirm the hypothesis that leptin is involved in the development of the hormonal and metabolic abnormalities in the PCOS.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S. Hahn, U. Haselhorst, B. Quadbeck, S. Tan, R. Kimmig, K. Mann, and O. E Janssen
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome
Eur. J. Endocrinol., February 1, 2006; 154(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang
Improving reproductive performance in overweight/obese women with effective weight management
Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Loffler, G. Aust, U. Kohler, and K. Spanel-Borowski
Evidence of leptin expression in normal and polycystic human ovaries
Mol. Hum. Reprod., December 1, 2001; 7(12): 1143 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, S. M. Pincus, M. C. Garcia-Rudaz, M. G. Ropelato, M. E. Escobar, and M. Barontini
Disruption of the Synchronous Secretion of Leptin, LH, and Ovarian Androgens in Nonobese Adolescents with the Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3772 - 3778.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.M. Spritzer, M. Poy, D. Wiltgen, L.S. Mylius, and E. Capp
Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements
Hum. Reprod., July 1, 2001; 16(7): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.B. Tiras, R. Yalcin, V. Noyan, I. Maral, M. Yildirim, O. Dortlemez, and S. Daya
Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome
Hum. Reprod., August 1, 1999; 14(8): 1949 - 1952.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Sir-Petermann, V. Piwonka, F. Perez, M. Maliqueo, S.E. Recabarren, and L. Wildt
Are circulating leptin and luteinizing hormone synchronized in patients with polycystic ovary syndrome?
Hum. Reprod., June 1, 1999; 14(6): 1435 - 1439.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. D. Brannian, Y. Zhao, and M. McElroy
Leptin inhibits gonadotrophin-stimulated granulosa cell progesterone production by antagonizing insulin action
Hum. Reprod., June 1, 1999; 14(6): 1445 - 1448.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.